HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CRN Action Plan Proactive Research Agenda-Setting Role Highlighted

This article was originally published in The Tan Sheet

Executive Summary

The Council for Responsible Nutrition will take a more focused, proactive role in dietary supplement research by helping influence what types of studies are conducted, CRN VP-Science & Research Cathy Fomous, PhD, announced at the association's annual conference in Miami Sept. 17-20.

You may also be interested in...



NIH St. John's Wort Study Focus On Major Depression Criticized By CRN Panel

A National Institutes of Health-funded study on St. John's wort and major depression likely will show a "very poor response rate" because the botanical is indicated only for treatment of mild to moderate depression, a former NIH official said at a Council for Responsible Nutrition press briefing June 25.

New Supplement Marketer Alliance Creating Multi-Prong PR Campaign

A collaboration of dietary supplement trade groups and individual manufacturers aims to raise $5 mil. to support a multi-year media campaign featuring standard PR, advertising and the Internet.

NSF Supplement Certification Program Eyes Early March Launch

A new dietary supplement standards certification program operated by NSF International could serve as an implementation platform for eventual federal GMP regulations.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS132924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel